Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition Implications for a potential anticoagulant effect of abciximab - Dangas, G; Badimon, J; Coller, B (Arterioscler Thromb Vasc Biol, 1998)
et al.